ALS ALS
Stories About

ALS

Brian Wallach and Sandra Abrevaya at their home in suburban Chicago. Jamie Kelter Davis for NPR hide caption

toggle caption
Jamie Kelter Davis for NPR

He was diagnosed with ALS. Then they changed the face of medical advocacy

  • Download
  • <iframe src="https://www.npr.org/player/embed/1184806340/1185303288" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

People participate in one last ice bucket challenge during the last annual "Plunge 4 Pete" on what would have been Pete Frates 35th birthday on Dec. 28, 2019 in Gloucester, MA. Jessica Rinaldi/Boston Globe via Getty Images hide caption

toggle caption
Jessica Rinaldi/Boston Globe via Getty Images

Participants tip buckets of ice water over their heads as they take part in the World Record Ice Bucket Challenge at Etihad Stadium on Aug. 22, 2014, in Melbourne, Australia. Scott Barbour/Getty Images hide caption

toggle caption
Scott Barbour/Getty Images

A controversial new drug for ALS that just received FDA approval could add months to patients' lives, but some scientists question whether it actually works. Manuel Balce Ceneta/AP hide caption

toggle caption
Manuel Balce Ceneta/AP

ALS drug's approval draws cheers from patients, questions from skeptics

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1126267087/1126295756" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The drugmaker Amylyx is asking the FDA to approve a new medication for ALS, a fatal neurodegenerative disease. It's possible the agency could greenlight the drug by the end of the month. Manuel Balce Ceneta/AP hide caption

toggle caption
Manuel Balce Ceneta/AP

FDA seems poised to approve a new drug for ALS, but does it work?

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1124138839/1124441200" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Researchers examined all 19,423 NFL players who took the field for at least one game from 1960 to 2019 in what the scientists said was the largest study of ALS risk in professional football players. Katelyn Mulcahy/Getty Images hide caption

toggle caption
Katelyn Mulcahy/Getty Images

Scientists at the Allen Institute for Brain Science uncovered differences among human brain cells (left) those of the marmoset monkey (middle) and mouse in a brain region that controls movement, the primary motor cortex. Allen Institute for Brain Science hide caption

toggle caption
Allen Institute for Brain Science

New brain maps could help the search for Alzheimer's treatments

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1043745117/1043788310" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Once the rules for implementing it are worked out, a bill signed into federal law in December will eliminate the required five-month waiting period for diagnosed ALS patients to begin disability benefits, enabling quicker Medicare coverage as well. LumiNola/Getty Images hide caption

toggle caption
LumiNola/Getty Images

Patients with a fast-progressing form of ALS who got daily doses of an experimental two-drug combination called AMX0035 scored higher on a standard measure of function than patients who didn't get the drug. Zephyr/Science Source hide caption

toggle caption
Zephyr/Science Source

Drug Combination Slows Progression Of ALS And Could Mark 'New Era' In Treatment

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/908874110/908874111" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

This light micrograph from the brain of someone who died with Alzheimer's disease shows the plaques and neurofibrillary tangles that are typical of the disease. A glitch that prevents healthy cell structures from transitioning from one phase to the next might contribute to the tangles, researchers say. Jose Luis Calvo/ Science Source hide caption

toggle caption
Jose Luis Calvo/ Science Source

Pete Frates, (seated, center) participates in the Ice Bucket Challenge with Massachusetts Gov. Charlie Baker to raise money for ALS research at the Statehouse in Boston in 2015. Charles Krupa/AP hide caption

toggle caption
Charles Krupa/AP

Stephanie Rinka in her beach wheelchair at Fort Fisher State Recreation Area, North Carolina. Courtesy of John Rinka hide caption

toggle caption
Courtesy of John Rinka

Adox and Michaeli with their son, Orion, in the winter of 2015. Courtesy of Christine Gatti hide caption

toggle caption
Courtesy of Christine Gatti

A Dying Man's Wish To Donate His Organs Gets Complicated

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/499494248/506971668" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Karen Lorne, diagnosed with Lou Gehrig's disease in July, volunteers weekly with her certified therapy dog, Bailey, at the Ronald McDonald House in Chapel Hill, N.C. Courtesy of Karen Lorne hide caption

toggle caption
Courtesy of Karen Lorne

Simplified Study Aims To Quickly Test A Long-Shot ALS Treatment

Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/499328778/499343677" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript